SRIDEVI DEVARAJ to Nitric Oxide Synthase Type III
This is a "connection" page, showing publications SRIDEVI DEVARAJ has written about Nitric Oxide Synthase Type III.
Connection Strength
0.691
-
Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem. 2009 Feb; 55(2):206-8.
Score: 0.294
-
C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase. Clin Chem. 2010 Aug; 56(8):1345-8.
Score: 0.081
-
Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis. 2009 Sep; 206(1):61-8.
Score: 0.074
-
The evolving role of C-reactive protein in atherothrombosis. Clin Chem. 2009 Feb; 55(2):229-38.
Score: 0.074
-
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol. 2007 Dec; 43(6):780-91.
Score: 0.067
-
Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1359-63.
Score: 0.057
-
The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res. 2007 Mar; 48(3):509-12.
Score: 0.016
-
Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation. 2006 May 02; 113(17):2135-50; discussion 2150.
Score: 0.015
-
Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002 Sep 17; 106(12):1439-41.
Score: 0.012